Assessing Patients for Hereditary Cancer Risk - Genetics 101 - Ambry Genetics

Explore a comprehensive webinar on identifying patients at risk for hereditary cancer and the benefits of genetic testing. Learn about the differences between hereditary and sporadic cancer, germline and somatic mutations, and tumor suppressor genes. Discover tools and skills used to identify at-risk patients, including NCCN guidelines and professional organization recommendations. Delve into the history and types of genetic testing, panel testing, and the distinction between high and moderate risk cancer genes. Gain insights on universal cancer screening, family history findings, and considerations for testing children and adolescents. Address questions about life insurance implications, PanHematological cancer panels, and preimplantation genetic testing. Presented by Emily Dalton, MS, CGC, Director of Genetic Specialists at Ambry Genetics, this 56-minute session equips healthcare professionals with valuable knowledge to assess and counsel patients regarding hereditary cancer risk.

Introduction
Meet Emily Dalton
Justice for Today
hereditary cancer vs sporadic cancer
mutation vs hereditary cancer
cancer breakdown
sporadic vs inherited
germline vs somatic mutations
denovo mutations
tumor suppressor genes
hereditary cancer types
how to identify hereditary cancer patients
tools to identify hereditary cancer patients
professional organizations
benefits
tools
NCCN guidelines
What is genetic testing
History of genetic testing
Benefits of genetic testing
Types of cancer genes
High vs moderate risk
Panel testing
Recap
Questions
Universal Cancer Screening
Pocket Cards
Family History Findings
Life Insurance
Testing Children and Adolescents
PanHematological Cancer Panels
PreImplantation Genetic Testing
ETCI vs Genetic Testing